CPT CODE

CPT Code 90717 for Yellow Fever Vaccination

In the intricate ecosystem of healthcare, a single medical encounter is a confluence of clinical expertise and administrative precision. Nowhere is this duality more apparent than in the realm of immunizations. For a patient, receiving a yellow fever vaccine is a simple, albeit important, step in preparing for an international adventure. For the healthcare provider, however, it represents a carefully orchestrated procedure involving clinical assessment, patient education, precise documentation, and, crucially, accurate medical coding to ensure appropriate reimbursement for services rendered.

The Current Procedural Terminology (CPT) code for yellow fever vaccination, 90717, is far more than a random identifier. It is a key that unlocks the financial viability of travel medicine clinics, public health departments, and primary care practices offering this essential service. Misunderstanding or misapplying this code can lead to claim denials, lost revenue, and even compliance issues. This article delves deep into the world of CPT code 90717, moving beyond a simple definition to explore its clinical context, proper application, administrative nuances, and its critical role within the broader framework of global public health. Whether you are a healthcare provider, a medical coder, a practice manager, or a curious patient, understanding this code is to understand a vital component of modern preventive medicine.

CPT Code 90717 for Yellow Fever Vaccination

CPT Code 90717 for Yellow Fever Vaccination

2. Understanding the Yellow Fever Threat: A Brief Medical Overview

To truly appreciate the importance of the service represented by CPT 90717, one must first understand the significant medical threat it helps to mitigate.

The Virus and Its Transmission
Yellow fever is an acute viral hemorrhagic disease caused by the Yellow Fever virus, which belongs to the genus Flavivirus. It is primarily transmitted to humans through the bite of infected Aedes and Haemagogus mosquitoes. The disease is endemic in tropical and subtropical areas of Africa and Central and South America. The cycle of transmission can be jungle (sylvatic), intermediate (savannah), or urban, with the urban cycle involving transmission between humans and urban-dwelling Aedes aegypti mosquitoes, potentially causing large epidemics.

Clinical Presentation and Global Impact
The incubation period is typically 3-6 days. Many infections are asymptomatic, but when symptoms occur, they can range from a mild, flu-like illness to a severe disease characterized by high fever, jaundice (which gives the disease its name), bleeding (hemorrhage), shock, and multi-organ failure. The case-fatality rate for severe cases can be as high as 50%. There is no specific antiviral treatment for yellow fever; care is primarily supportive, focusing on managing symptoms and combating dehydration and fever.

The World Health Organization (WHO) estimates there are 200,000 cases of yellow fever annually, causing 30,000 deaths, with 90% occurring in Africa. The historical impact of the disease is profound, having shaped trade, exploration, and military campaigns for centuries.

The Critical Role of Vaccination
Vaccination is the single most important and effective preventive measure against yellow fever. A single dose of the live, attenuated vaccine (such as the 17D-204 or 17DD strains) provides sustained immunity and lifelong protection for most people, as recognized by the WHO since 2014. The vaccine is highly effective, inducing protective immunity in over 95% of vaccines within 10 days and in 99% within 30 days. It is not just a personal protective measure; it is a tool for herd immunity and preventing international spread. This is why many countries with yellow fever risk, as well as countries where the mosquito vector is present, require proof of vaccination for entry via an International Certificate of Vaccination or Prophylaxis (ICVP), often called the “yellow card.”

3. The Cornerstone of Medical Billing: An Introduction to CPT Codes

Before we isolate code 90717, it is essential to understand the system it belongs to.

What is the CPT Code System?
The Current Procedural Terminology (CPT®) code set is a medical code set maintained by the American Medical Association (AMA). It is used to describe medical, surgical, and diagnostic services provided by physicians and other healthcare professionals. CPT codes are the standard language for communicating what services were performed to payers (insurance companies, Medicare, Medicaid) for the purposes of reimbursement. The codes are five-digit numeric codes that are updated annually to reflect advances in medicine and the introduction of new services.

The Importance of Precision in Coding
Accuracy in CPT coding is non-negotiable. It is the fundamental basis for:

  • Reimbursement: Correct codes ensure the provider is paid accurately and promptly for their services.

  • Data Analytics: Aggregated coding data is used for public health tracking, research, and shaping healthcare policy.

  • Compliance: Using an incorrect code, whether unintentionally or deliberately, can be considered fraud or abuse and can lead to audits, hefty fines, and legal consequences.

  • Efficiency: Standardized codes streamline the billing process between providers and payers.

4. CPT Code 90717 Demystified: The Specifics of Yellow Fever

At the heart of this article is a single, powerful code.

Code Description and Official Language
According to the AMA CPT Professional Edition, CPT code 90717 is defined simply as:
“Yellow fever vaccine, live, for subcutaneous use.”

This succinct description belies the complexity of what it represents. This code specifically identifies the product itself—the vial of vaccine. It is classified within the CPT manual’s Medicine section under the subsection “Vaccines, Toxoids.”

What Does the Code Include? Unpacking the Components of Care
It is a critical distinction to understand that 90717 represents the cost of the vaccine product only. When a provider purchases the vaccine from a manufacturer or distributor, they incur a significant cost. Code 90717 is the mechanism to recoup that expense. The payment for this code is intended to cover:

  • The acquisition cost of the vaccine.

  • The cost of storing and handling the vaccine (which often requires a specific cold chain protocol).

  • Any wastage (e.g., from a broken vial or a no-show patient).

It does not include:

  • The physical act of injecting the vaccine (the administration).

  • The medical decision-making involved in determining the patient’s suitability for the vaccine.

  • The counseling provided to the patient on risks, benefits, side effects, and travel health advice.

  • The supplies used (alcohol swab, syringe, bandage).

  • The completion and validation of the official “yellow card” (ICVP).

These additional services are captured by separate CPT and HCPCS Level II codes.

5. Beyond the Code: Administration and Counseling (CPT 90471)

A vaccination encounter is a two-part process: the product and the service. Therefore, billing is almost always a two-code process.

The Separation of Product and Service
CPT code 90717 is a “vaccine code.” To bill for the work involved in giving the shot, you must use an “administration code.” The most common administration code used for a yellow fever vaccine is 90471.

CPT 90471 is defined as:
“Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid).”

This code covers:

  • Confirming patient identity and verifying the correct vaccine.

  • Preparing the vaccine (drawing it into a syringe).

  • Cleaning the injection site.

  • Administering the injection.

  • Applying a bandage.

  • Documenting the lot number, expiration date, and injection site in the patient’s record.

If other services are provided during the same encounter—such as a significant and separate evaluation and management (E/M) service for a new travel health consultation—a separate E/M code (e.g., 99204) may also be appropriate, appended with a modifier (like -25) to indicate a separately identifiable service.

6. A Practical Walkthrough: Billing for a Yellow Fever Vaccination Encounter

Let’s translate this theory into a practical scenario.

Scenario: A Travel Clinic Visit
A 42-year-old patient presents to a certified travel clinic for a pre-trip consultation for an upcoming trek in Brazil. The clinician performs a review of the patient’s itinerary, medical history, and vaccination record. It is determined that the yellow fever vaccine is required and recommended. The patient consents. The nurse administers a single subcutaneous injection of the yellow fever vaccine and provides the patient with a completed and stamped ICVP.

Step-by-Step Coding Breakdown
The medical coder for the clinic would assign the following codes for this encounter:

  1. CPT 90717: For the yellow fever vaccine product.

  2. CPT 90471: For the administration of the single vaccine.

  3. ICD-10-CM Z71.89: “Other specified counseling” or, more precisely, Z71.1: “Person with feared health complaint in whom no diagnosis is made” can be used, but the most direct code is often Z23: “Encounter for immunization.” For the “reason” behind the immunization, a diagnosis code of Z77.121: “Contact with and (suspected) exposure to other viral diseases” might be used to indicate potential exposure during travel.

The Superbill: Documenting for Reimbursement
These codes would be listed on the encounter form (superbill) along with the appropriate charges for the vaccine and the administration fee. The practice’s billing staff would then submit these codes electronically to the patient’s insurance company.

7. Navigating the Financial Landscape: Reimbursement and Payer Policies

Understanding the codes is half the battle; understanding how they are paid is the other.

Understanding Medicare, Medicaid, and Private Payers

  • Medicare: Traditional Medicare (Part B) does not cover the yellow fever vaccine because it is not deemed medically necessary for life in the United States, where the disease is not endemic. Medicare will typically deny claims for 90717 and 90471. Patients must pay out-of-pocket.

  • Medicaid: Coverage varies significantly by state. Some state Medicaid programs may cover travel vaccines for specific reasons (e.g., missionary work), but most do not. It is essential to check state-specific guidelines.

  • Private Payers: This is highly variable. Some private insurance plans, especially those with broader preventive care or travel medicine benefits, may cover the vaccine. However, many consider it an elective “travel” service and exclude it from coverage. The onus is often on the patient to verify their benefits beforehand.

The Challenge of Patient-Paid Services
Because coverage is inconsistent, yellow fever vaccination is frequently a cash-based service. Practices must establish clear financial policies, including:

  • Informing patients of the likely out-of-pocket cost before the service is rendered.

  • Requiring payment at the time of service.

  • Providing patients with a detailed receipt containing the CPT (90717, 90471) and ICD-10 (Z23) codes should they wish to self-submit a claim to their insurer for possible reimbursement.

Strategies for Verifying Coverage and Preventing Denials
To minimize denials and patient confusion, practices should:

  1. Train staff to ask patients to call their insurer before their appointment to ask: “Does my plan cover the yellow fever vaccine (CPT 90717) and its administration (CPT 90471) for international travel?”

  2. Have patients sign an “Advance Beneficiary Notice of Noncoverage (ABN)” if billing Medicare, confirming they understand they are responsible for payment.

  3. Use the correct ICD-10 diagnosis codes that accurately reflect the purpose of the visit (e.g., Z77.121 for exposure) to support medical necessity.

8. The Crucial Link: Medical Documentation and Compliance

The patient’s medical record must robustly support the codes billed. In the event of an audit, the documentation is the ultimate proof of service.

What Must Be in the Patient’s Record
For each vaccine administered, the record should include:

  • Date of administration.

  • Vaccine name (Yellow Fever).

  • Vaccine manufacturer.

  • Lot number and expiration date.

  • Route of administration (subcutaneous).

  • Dosage.

  • Site of administration (e.g., left deltoid).

  • Name, title, and signature of the person administering the vaccine.

  • Address of the clinic where administered.

  • The Vaccine Information Statement (VIS) provided to the patient and the date it was given.

  • Documentation of any counseling on common side effects (e.g., low-grade fever, headache, muscle aches, injection site soreness) and rare but serious adverse reactions.

  • A copy of the completed ICVP (“yellow card”) should be included in the record or noted as having been provided.

Avoiding Fraud, Waste, and Abuse with Accurate Documentation
Billing for a vaccine that was not documented as given is fraud. Billing for an administration without noting the details is sloppy and can lead to recoupments. Consistent and thorough documentation is the best defense against allegations of improper billing and is a cornerstone of ethical medical practice.

9. Global and Public Health Considerations: The ICD-10 Connection

Coding extends beyond billing into the realm of public health surveillance.

Linking Diagnosis to Service: The Role of Z Codes
While CPT codes describe the procedure, ICD-10-CM codes describe the reason for the procedure. For immunizations, the encounter is typically coded first with Z23, “Encounter for immunization.” However, for travel vaccines, a secondary code from Chapter 21 of ICD-10-CM (Factors influencing health status and contact with health services) is crucial for data tracking. Key codes include:

  • Z77.121: Contact with and (suspected) exposure to other viral diseases (commonly used for yellow fever).

  • Z71.89: Other specified counseling (can be used for travel health counseling).

  • The specific codes for the country of travel under Z77.1- series (e.g., Z77.121 for exposure in Brazil).

The Importance of Reporting to the WHO and CDC
Yellow fever vaccination data, particularly from designated Yellow Fever Vaccination Centers, contributes to global surveillance efforts. While not directly tied to the CPT code, the act of vaccination and its documentation helps national bodies (like the CDC) and international bodies (like the WHO) monitor vaccination coverage, assess disease risk in specific areas, and inform international travel health recommendations. Accurate coding and documentation at the clinic level feed into this larger public health data ecosystem.

10. Frequently Asked Questions (FAQs)

Q1: My doctor’s office is charging over $200 for the yellow fever shot. Why is it so expensive?
A: The cost is high primarily due to the expense of the vaccine product itself (CPT 90717). The manufacturer’s price is significant. The total charge also includes the administration fee (CPT 90471) to cover the clinic’s staff time, overhead for storing the vaccine in specialized refrigeration, and the cost of supplies. Many clinics also bundle a brief travel health consultation into the fee.

Q2: Will my health insurance cover the cost of the yellow fever vaccine?
A: It depends entirely on your specific insurance plan. Medicare and many Medicaid plans do not cover it. Some private plans do, especially if deemed medically necessary rather than just for travel. It is your responsibility to contact your insurance company before your appointment to verify your benefits for CPT codes 90717 and 90471.

Q3: The clinic gave me a receipt with CPT codes 90717 and 90471. What should I do with it?
A: If your insurance does not cover the service and you paid out-of-pocket, keep this receipt for your records. You can submit it along with your insurer’s claim form to see if they will provide any reimbursement. You may also be able to use the cost toward your Flexible Spending Account (FSA) or Health Savings Account (HSA) if you have one.

Q4: Are the vaccine product code and the administration code always billed together?
A: In the vast majority of cases, yes. You cannot bill for administering a vaccine that wasn’t given (90471 without 90717), and you should not bill for a vaccine that was not administered (90717 without 90471). They represent two distinct parts of the same service.

Q5: How often do I need to get the yellow fever vaccine?
A: Since 2016, the World Health Organization (WHO) has stated that a single dose of yellow fever vaccine provides lifelong protection. This is reflected in the International Certificate of Vaccination (yellow card). However, some countries may still have requirements based on their own national policies. Always check the specific entry requirements for your destination.

11. Conclusion: The Vital Intersection of Clinical Care and Administrative Accuracy

The simple code 90717 is a nexus where clinical medicine, administrative precision, and global public health converge. Its correct application ensures that healthcare providers can sustainably offer a lifesaving preventive service. Understanding the distinction between the product and the administration fee is fundamental to transparent billing and patient communication. Ultimately, the accurate use of this code supports not only the financial health of a practice but also the physical health of populations worldwide by facilitating access to a crucial tool in the fight against a deadly disease.

12. Additional Resources

For the most accurate and up-to-date information, always consult these primary sources:

 

Date: September 11, 2025
Author: Public Health & Medical Billing Insights Team
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute medical, coding, or legal advice. Medical coding is complex and subject to change. Always consult the most current AMA CPT® manual, payer-specific policies, and certified professional coders for accurate billing and coding guidance. The author and publisher are not responsible for any errors or omissions or for any outcomes related to the use of this information.

About the author

wmwtl